/Comparative Effectiveness of Anbalcabtagene Autoleucel versus Tisagenlecleucel in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma

Reviews

Join the dialogue

Submit a peer review to improve the scientific record